Episode
How Private Equity Is Buying Up Marijuana Dispensaries
- Published
- Jun 24, 2026
- Duration seconds
- 669
- Processing state
not_requested
Actions
POST https://stenobird.com/v1/public/podcasts/the-buyout-show-with-fexingo-private-equity-roll-ups-and-business-acquisitions-7871630/episodes/how-private-equity-is-buying-up-marijuana-dispensaries/transcription-requests
Idempotently request low-priority transcript generation for this episode.GET https://stenobird.com/podcast/the-buyout-show-with-fexingo-private-equity-roll-ups-and-business-acquisitions-7871630/how-private-equity-is-buying-up-marijuana-dispensaries.md
Read the agent-friendly Markdown representation of this episode resource.
Summary
Episode 72 of The Buyout Show explores the growing wave of private equity investment in legal cannabis dispensaries across the United States. With federal rescheduling on the horizon in mid-2026, firms like Curaleaf and Green Thumb Industries are consolidating smaller operators at a rapid clip. Lucas and Luna break down the economics: how the average dispensary acquisition multiple has climbed from 6x to 9x EBITDA in two years, the role of state-level licensing bottlenecks, and why PE firms see cannabis as an infrastructure play rather than a growth bet. They also examine the risks — from regulatory whiplash to 280E tax burdens — and debate whether this roll-up mirrors the urgent-care consolidation wave or something entirely new. A concrete case: the recent acquisition of a 12-store chain in Michigan for $85 million by a New York-based PE firm. Specific, data-driven, and grounded in the week's news. #PrivateEquity #Cannabis #Dispensaries #RollUp #Marijuana #Curaleaf #GreenThumbIndustries #Michigan #Acquisition #Business #Finance #Investment #Regulation #280E #Consolidation #FexingoBusiness #BusinessPodcast #TheBuyoutShow Keep every episode free: buymeacoffee.com/fexingo